These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. New vaccination technology for endogenous antigen-derived ailments. Barabas AZ; Cole CD; Barabas AD; Bahlis NJ; Lafreniere R IDrugs; 2008 Feb; 11(2):111-5. PubMed ID: 18240096 [TBL] [Abstract][Full Text] [Related]
5. A modified vaccination technique for the prevention and treatment of an experimental autoimmune kidney disease. Barabas AZ; Cole CD; Barabas AD; Lafreniere R Ann N Y Acad Sci; 2007 Sep; 1110():619-29. PubMed ID: 17911477 [TBL] [Abstract][Full Text] [Related]
6. Harnessing self-reactivity in cancer immunotherapy. Schoenberger SP; Sercarz EE Semin Immunol; 1996 Oct; 8(5):303-9. PubMed ID: 8956459 [TBL] [Abstract][Full Text] [Related]
7. Definition of human autoimmunity--autoantibodies versus autoimmune disease. Lleo A; Invernizzi P; Gao B; Podda M; Gershwin ME Autoimmun Rev; 2010 Mar; 9(5):A259-66. PubMed ID: 19963079 [TBL] [Abstract][Full Text] [Related]
8. [Immunology in medical practice. XIX. Etiology and pathogenesis of auto-immune diseases]. de Vries RR; Roep BO Ned Tijdschr Geneeskd; 1999 May; 143(19):974-8. PubMed ID: 10368716 [TBL] [Abstract][Full Text] [Related]
10. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases]. Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605 [TBL] [Abstract][Full Text] [Related]
11. The T cell receptor in autoimmune diseases. Bluestone JA; Spencer C; Hirsch R J Rheumatol Suppl; 1992 Apr; 33():75-7. PubMed ID: 1534379 [TBL] [Abstract][Full Text] [Related]
12. Selective targeting of the immune response in autoimmune demyelination. Oksenberg JR West J Med; 1994 Sep; 161(3):255-9. PubMed ID: 7975563 [TBL] [Abstract][Full Text] [Related]
13. The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. Shoenfeld Y; Selmi C; Zimlichman E; Gershwin ME J Autoimmun; 2008 Dec; 31(4):325-30. PubMed ID: 18838248 [TBL] [Abstract][Full Text] [Related]
14. Rational design of peptide vaccines for autoimmune disease: harnessing molecular recognition to fix a broken network. Weathington NM; Blalock JE Expert Rev Vaccines; 2003 Feb; 2(1):61-73. PubMed ID: 12901598 [TBL] [Abstract][Full Text] [Related]
15. Tolerance, loss of tolerance and regaining tolerance to self by immune-mediated events. Barabas AZ; Cole CD; Graeff RM; Lafreniere R; Weir DM Immunol Res; 2017 Feb; 65(1):402-409. PubMed ID: 27456203 [TBL] [Abstract][Full Text] [Related]
16. Animal models of endocrine/organ-specific autoimmune diseases: do they really help us to understand human autoimmunity? Lam-Tse WK; Lernmark A; Drexhage HA Springer Semin Immunopathol; 2002 Dec; 24(3):297-321. PubMed ID: 12503056 [TBL] [Abstract][Full Text] [Related]